BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20178979)

  • 1. The anti-tumorigenic properties of peroxisomal proliferator-activated receptor alpha are arachidonic acid epoxygenase-mediated.
    Pozzi A; Popescu V; Yang S; Mei S; Shi M; Puolitaival SM; Caprioli RM; Capdevila JH
    J Biol Chem; 2010 Apr; 285(17):12840-50. PubMed ID: 20178979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisomal proliferator-activated receptor-alpha-dependent inhibition of endothelial cell proliferation and tumorigenesis.
    Pozzi A; Ibanez MR; Gatica AE; Yang S; Wei S; Mei S; Falck JR; Capdevila JH
    J Biol Chem; 2007 Jun; 282(24):17685-95. PubMed ID: 17405874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPARα ligand, AVE8134, and cyclooxygenase inhibitor therapy synergistically suppress lung cancer growth and metastasis.
    Wu L; Wang W; Dai M; Li H; Chen C; Wang D
    BMC Cancer; 2019 Dec; 19(1):1166. PubMed ID: 31791289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPARα activation can help prevent and treat non-small cell lung cancer.
    Skrypnyk N; Chen X; Hu W; Su Y; Mont S; Yang S; Gangadhariah M; Wei S; Falck JR; Jat JL; Zent R; Capdevila JH; Pozzi A
    Cancer Res; 2014 Jan; 74(2):621-31. PubMed ID: 24302581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P450 CYP2C epoxygenase and CYP4A omega-hydroxylase mediate ciprofibrate-induced PPARalpha-dependent peroxisomal proliferation.
    Gatica A; Aguilera MC; Contador D; Loyola G; Pinto CO; Amigo L; Tichauer JE; Zanlungo S; Bronfman M
    J Lipid Res; 2007 Apr; 48(4):924-34. PubMed ID: 17234604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into the regulation of tumor dormancy by angiogenesis in experimental tumors.
    Indraccolo S
    Adv Exp Med Biol; 2013; 734():37-52. PubMed ID: 23143974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fenofibrate Inhibits Cytochrome P450 Epoxygenase 2C Activity to Suppress Pathological Ocular Angiogenesis.
    Gong Y; Shao Z; Fu Z; Edin ML; Sun Y; Liegl RG; Wang Z; Liu CH; Burnim SB; Meng SS; Lih FB; SanGiovanni JP; Zeldin DC; Hellström A; Smith LEH
    EBioMedicine; 2016 Nov; 13():201-211. PubMed ID: 27720395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Cyp2c44 epoxygenase regulates epithelial sodium channel activity and the blood pressure responses to increased dietary salt.
    Capdevila JH; Pidkovka N; Mei S; Gong Y; Falck JR; Imig JD; Harris RC; Wang W
    J Biol Chem; 2014 Feb; 289(7):4377-86. PubMed ID: 24368771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPARalpha deficiency in inflammatory cells suppresses tumor growth.
    Kaipainen A; Kieran MW; Huang S; Butterfield C; Bielenberg D; Mostoslavsky G; Mulligan R; Folkman J; Panigrahy D
    PLoS One; 2007 Feb; 2(2):e260. PubMed ID: 17327920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha.
    Ng VY; Huang Y; Reddy LM; Falck JR; Lin ET; Kroetz DL
    Drug Metab Dispos; 2007 Jul; 35(7):1126-34. PubMed ID: 17431031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbohydrate-binding protein CLEC14A regulates VEGFR-2- and VEGFR-3-dependent signals during angiogenesis and lymphangiogenesis.
    Lee S; Rho SS; Park H; Park JA; Kim J; Lee IK; Koh GY; Mochizuki N; Kim YM; Kwon YG
    J Clin Invest; 2017 Feb; 127(2):457-471. PubMed ID: 27991863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous epoxygenases are modulators of monocyte/macrophage activity.
    Bystrom J; Wray JA; Sugden MC; Holness MJ; Swales KE; Warner TD; Edin ML; Zeldin DC; Gilroy DW; Bishop-Bailey D
    PLoS One; 2011; 6(10):e26591. PubMed ID: 22028915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The arachidonic acid epoxygenase is a component of the signaling mechanisms responsible for VEGF-stimulated angiogenesis.
    Yang S; Wei S; Pozzi A; Capdevila JH
    Arch Biochem Biophys; 2009 Sep; 489(1-2):82-91. PubMed ID: 19464254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sox17 promotes tumor angiogenesis and destabilizes tumor vessels in mice.
    Yang H; Lee S; Lee S; Kim K; Yang Y; Kim JH; Adams RH; Wells JM; Morrison SJ; Koh GY; Kim I
    J Clin Invest; 2013 Jan; 123(1):418-31. PubMed ID: 23241958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated basal expression of liver peroxisomal beta-oxidation enzymes and CYP4A microsomal fatty acid omega-hydroxylase in STAT5b(-/-) mice: cross-talk in vivo between peroxisome proliferator-activated receptor and signal transducer and activator of transcription signaling pathways.
    Zhou YC; Davey HW; McLachlan MJ; Xie T; Waxman DJ
    Toxicol Appl Pharmacol; 2002 Jul; 182(1):1-10. PubMed ID: 12127257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stromal fibroblasts activated by tumor cells promote angiogenesis in mouse gastric cancer.
    Guo X; Oshima H; Kitmura T; Taketo MM; Oshima M
    J Biol Chem; 2008 Jul; 283(28):19864-71. PubMed ID: 18495668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epoxygenases CYP2J2 activates the nuclear receptor PPARalpha in vitro and in vivo.
    Wray JA; Sugden MC; Zeldin DC; Greenwood GK; Samsuddin S; Miller-Degraff L; Bradbury JA; Holness MJ; Warner TD; Bishop-Bailey D
    PLoS One; 2009 Oct; 4(10):e7421. PubMed ID: 19823578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiangiogenic effect of inhibitors of cytochrome P450 on rats with glioblastoma multiforme.
    Zagorac D; Jakovcevic D; Gebremedhin D; Harder DR
    J Cereb Blood Flow Metab; 2008 Aug; 28(8):1431-9. PubMed ID: 18414496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization.
    Ogawa K; Pasqualini R; Lindberg RA; Kain R; Freeman AL; Pasquale EB
    Oncogene; 2000 Dec; 19(52):6043-52. PubMed ID: 11146556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome p450 epoxygenase promotes human cancer metastasis.
    Jiang JG; Ning YG; Chen C; Ma D; Liu ZJ; Yang S; Zhou J; Xiao X; Zhang XA; Edin ML; Card JW; Wang J; Zeldin DC; Wang DW
    Cancer Res; 2007 Jul; 67(14):6665-74. PubMed ID: 17638876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.